Active Clinical Trials

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

By April 24, 2017 No Comments


Malignant Pleural Effusion|Lung Cancer|Mesothelioma|Breast Cancer|Ovarian Cancer

Estimated Enrollment: 19

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: MpeTK01

Study First Received: November 19, 2013

Last Updated: December 30, 2016

Estimated Primary Completion Date: December 2015


Primary Outcome Measures:

Safety|Progression-free survival|Overall survival

Sponsors and Collaborators:

Advantagene, Inc.|University of Pennsylvania

Website Link:

Leave a Reply

Call Now ButtonCall Now